(PharmaNewsWire.Com, July 20, 2017 ) The market is showcasing evident potential in the mentioned forecasting period. It is expected to show significant growth in coming years because of the people being habitual of indulging in poor eating habits and resultantly facing stomach problems. The number of cases of people falling sick have been rising significantly lately.
Antacid are medical compounds used to treat excess acidity in stomach, which in turn relieves stomach upset, heartburn and indigestion. In case of excessive secretion of acids in the digestive system, the natural mucous barrier responsible for protecting the lining in the stomach can damage the oesophagus. Increasing rate people experiencing stomach problems has led to companies gaining interest in the Antacids market recently.
Antacids directly target the excess acids and get rid of them unlike other medications which just reduce or prevent stomach acid excretion. Thus, it shows better results as compared to other medications. Further, Antacid are available either as a chewable gum, liquid or a tablet, hence being easy to use for patients across all age groups. These factors have been responsible for driving the growth of the Antacid market lately. On the other side, there are few restraints that are faced by antacids market which include certain side effects like laxative effect, constipation, allergic reactions. Further, people with specific medical conditions are prone to adverse side effects on their health conditions, like people with heart conditions may face problems because of high amount of sodium present in Antacids.
The North America market for Antacid is segmented based on applications, submarkets, and ingredients. By submarkets the market is segmented under E-Clinical Trial Solutions, Chromatography, Wireless Health, Healthcare IT outsourcing, Clinical Trial Management Systems(CTMS), Immunoassay, Next Generation sequencing(NGS), Digital Pathology, Antacids with Antiflatulents, Proteomics. By Application the market is segment under Novel dietary fibers. According to ingredients the market is segmented under Modified starch, Protease, Food & Beverage Starch, Collagen, Carbohydrase, Gelatin, Food & Beverage Sugars & its substitutes. Under the submarket segmentation, Chromatography held the highest share in the market followed by the share of Clinical Trial Management Systems (CTMS). Based on segmentation by Ingredients, protease leads the market share. On the basis of geographical analysis, the North America market is analysed under various countries namely USA and Canada.
Some of the major companies in the Antacid market include WellSpring Pharm, First Aid Only, GSK, Private Lable, Procter & Gamble, Pfizer, Glaxosmithkline, Novaritis Consurmer Health, Boehringer Ingellheim Pharm, Johnson & Johnson.
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
